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protease activity involved in antigen processing
in human primary cells
Archana Vaithilingam1,2, Nicole Y Lai1, Ellen Duong1, Julie Boucau1,2, Yang Xu1, Mariko Shimada1,
Malini Gandhi1 and Sylvie Le Gall1,2*Abstract
Background: Endolysosomes play a key role in maintaining the homeostasis of the cell. They are made of a
complex set of proteins that degrade lipids, proteins and sugars. Studies involving endolysosome contribution to
cellular functions such as MHC class I and II epitope production have used recombinant endolysosomal proteins,
knockout mice that lack one of the enzymes or purified organelles from human tissue. Each of these approaches
has some caveats in analyzing endolysosomal enzyme functions.
Results: In this study, we have developed a simple methodology to assess endolysosomal protease activity. By
varying the pH in crude lysate from human peripheral blood mononuclear cells (PBMCs), we documented increased
endolysosomal cathepsin activity in acidic conditions. Using this new method, we showed that the degradation of
HIV peptides in low pH extracts analyzed by mass spectrometry followed similar kinetics and degradation patterns
as those performed with purified endolysosomes.
Conclusion: By using crude lysate in the place of purified organelles this method will be a quick and useful tool to
assess endolysosomal protease activities in primary cells of limited availability. This quick method will especially be
useful to screen peptide susceptibility to degradation in endolysosomal compartments for antigen processing
studies, following which detailed analysis using purified organelles may be used to study specific peptides.
Keywords: Endolysosome, Antigen processing, Proteases, Cathepsins, Protein degradation, Primary cells, Mass
spectrometry, T cell epitope production, MHC, HIVBackground
Endolysosomes are cellular organelles that play a key
role in protein turnover and homeostasis of the cell.
They are made up of a complex set of enzymes that
break down proteins, lipids and sugars that are all essen-
tial for normal functioning of the cell [1]. A genetic mu-
tation in some of these endolysosomal proteins can lead
to disorders such as Gaucher’s disease, Niemann pick’s
disease, and Fabry disease [2-5]. Endolysosomes also play
a key role in antigen presentation by processing large
proteins into epitopes that can be presented by MHC
Class I and Class II molecules [6-8]. Therefore it is* Correspondence: sylvie_legall@hms.harvard.edu
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distribution, and reproduction in any mediumimportant to develop methodologies suitable to study
specific endolysosomal functions in relevant cells and
tissues.
Several methods have been used to study their func-
tions in the cell. The approaches taken to study
endolysosome contribution to protein degradation in-
clude using recombinant cathepsins in peptide degra
dation assays [9], studying the effect of cathepsin knock-
out mice on the epitope repertoire [10], and using puri-
fied endolysosomes from human tissue as a source of
proteases for protein degradation assay [11]. In the case
of endolysosomal storage disorders, knock-in mice ex-
pressing a mutated form of an enzyme have been used
to study the role of specific proteins in disease [12].
Each of the above mentioned approaches have some
caveats. Endolysosomes comprise a complex set ofntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Studying the role of a single protease and their contribu-
tion to antigen presentation using recombinant proteins
is not representative of the complex milieu inside the or-
ganelle. Gene knock-out or siRNA studies are helpful in
identifying the precise role of a particular protein but do
not help in addressing the interactions between the dif-
ferent proteins in the organelle. Though using purified
endolysosomes will address the above-mentioned con-
cerns, it involves a laborious, multistep process and re-
sults in a much lesser yield. In studies involving limited
amount of material such as primary cells from patients,
it may not be feasible to purify endolysosomes.
In this study, we describe a simple approach to test
the contribution of endolysosomal proteases to protein
degradation. Since endolysosomal proteases are active in
acidic pH [13], we tested this characteristic by varying
the pH in crude peripheral blood mononuclear cell
(PBMC) lysate by varying the pH and showed that
endolysosomal cathepsin activity can be specifically acti-
vated at acidic pH. This simple yet efficient approach en-
abled us to test the contribution of endolysosomal
proteases to several cellular functions using primary cells
and therefore is physiologically relevant. We compared
these low pH extracts to purified endolysosomes and
found that both methodologies produced similar prote-
ase activities and peptide degradation kinetics. Here, we
exemplify the role of endolysosomes in antigen process-
ing and highlight the potential usefulness of this method
to study the function of endolysosomal enzymes in other
functions and human diseases.
Results
Differential centrifugation of PBMC lysate yields pure
endolysosomes
We purified endolysosomes from PBMC isolated from
the blood of healthy donors. Following differential cen-
trifugation enrichment of lysosomes was confirmed by
Western blot by probing for lysosomal associated mem-
brane protein 1 (LAMP1) and cathepsin S. Quantifica-
tion of the western blot bands showed a six-fold
enrichment of cathepsin S in the endolysosomal fraction.
This fraction was also devoid of cytosolic protein such
as proteasome subunit α7 and actin, and displayed a
five-fold reduced expression of endoplasmic reticulum
protein, calnexin (Figure 1A). To further confirm the
enrichment of endolysosomes, the activities of cathepsin,
chymotryptic activity of proteasomes and aminopep-
tidases were tested using a fluorescence-based activity
assay using a fluorogenic peptidase-specific substrate
(Suc-LLVY-AMC for chymotryptic activity of protea-
somes, H-L-AMC for aminopeptidase and Z-FR-AMC
for omnicathepsin) [14-16]. The substrate, made of a
short peptide linked to a fluorogenic coumarin derivativefluoresces only when the peptide is cleaved by the en-
zyme. The level of fluorescence emitted can be quanti-
fied over time. Whereas a high level of proteasomal and
aminopeptidase activities was detected in the lysosome-
depleted cytosolic fraction, purified endolysosomes exhi-
bited high cathepsin activity but no proteasomal activity
and aminopeptidase activity (Figure 1B). Specificity of
the substrate was measured by monitoring enzyme activ-
ity in the presence of specific or irrelevant inhibitors
(epoxomicin for proteosome, bestatin for aminopepti-
dase, EDTA as a metal chelator and E64 for cathepsin).
Each activity was strongly inhibited by the inhibitor for
the relevant enzyme but not by the other inhibitors.
Thirdly, we measured acid phosphatase, an activity
enriched in endolysosomes using a colorimetric assay
[17]. Acid phosphatase is one of the established lyso-
somal enzyme markers, and was used to monitor the
level of lysosome enrichment in the isolated fractions
following differential centrifugation [18]. Comparison of
phosphatase activities among different fractions showed
that fractions 3 to 6 had the highest phosphatase activity,
showing a ten-fold enrichment in acid phosphatase ac-
tivity compared to the cytosolic fraction (Figure 1C).
These three independent approaches confirmed the iso-
lation of endolysosomes and cytosol from crude PBMC
lysate.
Our previous studies established that short HIV pep-
tides are variably sensitive to cytosolic degradation, a
property that contributes to the efficient presentation of
MHC-I epitopes [15]. We reasoned that due to differ-
ences in the peptidase content between cytosol (prote-
asome, aminopeptidases, endopeptidases) and endolyso
somes (cathepsins) we may use differential peptide deg-
radation as an additional approach to assess cytosolic
and endolysosomal fraction purity, as well as a readout
of endolysosomal hydrolytic activities that does not in-
volve fluorogenic substrates. The percentage of acid
phosphatase activity in each fraction was used to deter-
mine the number of cells that yielded endolysosomes in
each fraction. For example, if fraction 4 consisted of 30%
of the total acid phosphatase activity, it was assumed
that 30% of the initial number of PBMC yielded the
endolysosomal proteins in that fraction. Using this infor-
mation to calculate equivalent amounts of cytosol and
endolysosome fractions purified from the same PBMC,
we compared the degradation of two HIV p24 Gag-
derived epitopes: B27KK10 (KRWIILGLNK, 131-140aa,
a ten amino acid long HIV peptide restricted by
HLA-B27), and B57KF11 (KAFSPEVIPMF, 30-40aa, an
11-amino acid long HIV peptide restricted by the HLA-
B57) [19] (Figure 1D). The disappearance of the peptide
was monitored by RP-HPLC, where the amount of pep-
tide is proportional to the surface area under its peak.
Upon degradation the peak area reduced and additional
Figure 1 Differential centrifugation of PBMC lysate yields fractions that are highly enriched in endolysosomes. (A) Enrichment of
endolysosomes in fractions recovered after differential centrifugation was assessed by western blot. PBMC lysate from which endolysosomes were
extracted (lane 1), fraction enriched in endolysosomal proteins LAMP1 and Cathepsin S (lane 2). (B) Isolated endolysosomal (light grey) and
cytosol depleted of lysosomal (dark grey) fractions were assayed for activity of cathepsins, aminopeptidases and chymotryptic activity of
proteasome in the presence of inhibitors Epoxomicin (Epox) for proteasome, Bestatin (Best) for aminopeptidase, E64 for cathepsins and EDTA as a
metal chelator. Mean and SD of replicates from two different donors are plotted. (C) Acid phosphatase assay was performed to confirm
enrichment of endolysosomes in different fractions. Figure representative of acid phosphatase activities in one fractionation experiment done in
triplicates. Mean and SD are plotted. (D) Two HIV Gag peptides, B57KF11 (KAFSPEVIPMF) and B27KK10 (KRWIILGLNK) were subjected to
degradation by equivalent amounts of purified cytosol (blue) or endolysosomes (red). An aliquot of the reaction mixture was stopped at periodic
intervals and the percentage of original peptide remaining was determined by HPLC. The half-life of the peptide in both conditions was
calculated (36 min in cytosol and 8 min in endolysosomes for B57KF11 and more than 60 min in cytosol and 38 min in endolysosome for
B27KK10). Figure 1D is representative of two replicates.
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[15]. The two HIV peptides were degraded faster in
endolysosomes compared to the cytosol. The half-life of
B57KF11 was 36 min in the cytosol and decreased to
8 min in endolysosomes. Similarly, the half-life of
B27KK10 was greater than 60 min in the cytosol and re-
duced to 38 min in the endolysosomes, suggesting that
the distinct sets of peptidases present in cytosol and
endolysosomes differently degraded the two peptides,
also providing further evidence of the purity of the
PBMC fractions.Cathepsin activities can be measured using crude lysate
at acidic pH
Purifying endolysosomes from crude lysate is a laborious
process and the yield is much lesser. We aimed to de-
velop a simple approach to test the activity of endoly
sosomal proteins to be used in assays with limited
amount of material using crude PBMC lysate. We also
made sure that cystatins do not affect cathepsin activity
in low pH extracts. Cystatins are cysteine protease inhi-
bitors present in the cytosol and reversibly bind and in-
hibit the activity of cathepsin [20]. We compared the
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pH crude lysate derived from the same number of cells.
We observed similar levels of enzyme activity in extracts
and live cells, showing no effect of cystatins in the meas-
urement of cathepsins in low pH extracts (Additional file
1: Figure S1). Additionally previous studies showed that
cystatins are susceptible to protein degradation at low
pH [21]. Since the assays we use hereafter are designed
to assess cathepsin activity in lower pH, the effect of
cystatin activity should be negligible. We first tested the
activity of Cathepsin B, K, D, and S present in the
endolysosomes at several pH ranging from two to nine,
since endolysosomal proteases are activated in acidic pH
[22]. Crude PBMC extracts were resuspended in a buffer
that was adjusted to the appropriate pH. We then added
fluorogenic substrates that were specific for cathepsins
S, D, K and B (Z-VVR-AMC for cathepsin S, Ac-
RGFFP-AMC for cathepsin D, Z-GPR-AMC for cathep-
sin K and Z-RR-AMC for cathepsin B) and also an
omni-cathepsin substrate (Z-FR-AMC) specific for all
cysteine cathepsins [16]. The fluorescence was moni-
tored for three to four hours after addition of crude
lysate and substrate. As a negative control, only PBS was
added in the place of crude lysate. We then calculated
the maximum slope of the fluorescence curve for each
cathepsin at all pH after background correction
(Figure 2). The experiment was repeated with PBMC
from three different healthy donors. Omni-cathepsin
substrate was cleaved best at pH 6.0 and 5.0, suggesting
that cysteine cathepsin activity is higher at acidic pH.
Cathepsin S, which has been implicated in antigenFigure 2 Optimal pH for activity of cathepsins. The activities of all cyste
in crude PBMC lysate were assayed using peptidase-specific fluorogenic su
2.0 to 9.0, fluorescence measured over time was plotted and the average m
each pH.processing showed high activity at pH 5.0 and 4.0. Ca-
thepsin B displayed higher activity at pH 6.0 whereas ca-
thepsin D and K showed higher activity at cytosolic pH
7.4. Several studies attribute endolysosomal enzymes
such as Cathepsin S to the production of Class I and II
epitopes [6,7,23,24], which exhibited ten-fold higher ac-
tivity in acidic pH 5.0 when compared to cytosolic pH
7.4. However Cathepsin D and Cathepsin K exhibited
eight to ten-fold higher activity in physiological pH 7.4.
Recent studies showed that in some cases, cathepsin K is
active at normal pH because it is secreted by the cells
and play a role in bone resorption [25] and this may ex-
plain increased activity of Cathepsin K in cytosolic pH.
In summary, PBMC cathepsins specifically involved in
protein processing are more active at acidic pH. We also
monitored the specificity of each substrate for the en-
zyme by adding cathepsin inhibitors to the mix and
found that cathepsin B substrate can be cleaved by ca-
thepsin S and cathepsin S substrate can be cleaved by
cathepsin B (Additional file 2: Figure S2). Despite this
cross-reactivity, the overall activity of cathepsin S and
cathepsin B covered different pH ranges (4–6 for cathep-
sin S and 6–8 for Cathepsin B which allows to distin-
guish them). In addition we used a peptide degradation
assay to monitor cathepsin activity at different pH with-
out the use of fluorescent substrates.
PBMC cathepsins involved in protein processing degrade
peptides at acidic pH
To demonstrate a functional consequence of the activation
of endolyosomal enzymes at acidic pH we used a peptideine cathepsins (Omni-cathepsin) and cathepsins S, B, K and D present
bstrates. The reaction buffer was adjusted so that the pH ranged from
aximum slope of the curve from three replicates was determined for
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determine if the cathepsins activated at different pH would
degrade peptides differently. These degradation assays were
performed in the presence of cathepsin inhibitors to
identify specific cathepsins that played a role in antigen
processing. B27KK10 was degraded with crude PBMC
lysate in a reaction buffer that ranged from pH 3.0 to 9.0.
The products of peptide degradation after 0, 10, 30 and 60
minutes of the reaction were analyzed by RP-HPLC and
the percentage of remaining original peptide was quantified
from the area under peak (Figure 3A). To rule out any ef-
fect of acidic pH on the peptides, the peptide was incubated
for the same amount of time with the reaction buffer with-
out any crude lysate and the peptide was quantified by RP-
HPLC (Figure 3B). As mentioned in Figure 1D, a half-life of
the peptide in the presence or absence of cathepsin can be
calculated. However, the half-life was not always apparent
because of slower degradation kinetics. Therefore, on fitting
a one-phase exponential decay curve, we calculated the sta-
bility rate of the peptide at each pH (Figure 3C). We previ-
ously showed that stability rate correlates with the half-lifeA 
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stability rate in the presence of inhibitors was calculated. In
the presence of Cathepsin S and Cathepsin D inhibitors,
the stability rate of the peptide increased 1.5- to 3.0-fold at
pH 4.0 and 5.0, indicating that the cleavage of the B27KK10
peptide required proteases that were activated only in acidic
conditions. Our previous results also showed that cytosolic
protease activities are completely eliminated at pH 4.0 and
5.0 [15], therefore indicating that peptide degradation at
acidic pH is performed exclusively by endolysosomal prote-
ases. No change in stability rate was noted in extremely
acidic pH 3.0 and neutral pH 7.0 and basic pH 8.0. The
experiment was repeated using PBMC lysate from three
different healthy donors and the average of three results are
shown in Figure 3C. In summary, using an alternative ap-
proach involving peptide degradation followed by HPLC
quantification rather than using fluorogenic enzyme sub-
strates we showed that endolysosomal proteases involved inPr
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that crude extracts at lower pH can be used to monitor
peptide degradation by these cathepsins.
Endolysosomes and crude lysate at acidic pH degrade
peptides with the same kinetics and produce similar
fragments
We then sought to determine if the kinetics of protein
degradation and the subsequent peptide fragments pro-
duced after degradation were similar when using purified
endolysosomes or crude PBMC lysate as a source of en-
zymes for protein processing. We performed a degrad-
ation assay as mentioned in Figure 1 and analyzed the
peptide fragments produced by mass spectrometry. We
compared the degradation of a longer HIV peptide rele-
vant to antigen processing and peptide-based immuno-
gens with crude lysate and purified endolysosomes at
pH 5.5 (late endosomal pH) and 4.0 (lysosomal pH) [26].
Based on results in Figures 2 and 3, we hypothesized
that specific sets of cathepsins will be activated at pH
5.5 versus pH 4.0 which would give rise to different pep-
tide fragments between the two conditions. We analyzed
the degradation products of a longer peptide, 5-KF11-3
(KVVEEKAFSPEVIPMFAAL amino acid residues 25–43),
a 19 amino acid long fragment from p24 protein in HIV-1
clade B encompassing epitope B57KF11 Figure (4). The
products of the degradation after a 60-minute incubation
with either crude lysate or purified endolysosomes at pH
4.0 and 5.5 were identified by mass spectrometry. At pH
4.0, a total of 39 peptides were identified in endolysosome-
mediated degradation and 32 peptides in the crude lysate-
mediated fraction. Of these, 27 peptides or 84.75% of the
fragments present in the crude lysate degradation fraction
were similar those produced in endolysosomes (Figure 4A).
Unique peptides produced under each condition can be
attributed to possible minor contribution cytosolic prote-
ases that retain some hydrolytic activity in low pH. At pH
5.5 we found that 76.2% of the peptides present in crude
lysate mediated degradation fraction were similar to the
endolysosomal fraction. Interestingly, common peptide
fragments detected in crude lysate and endolysosomal deg-
radation conditions contributed to 99% of overall peptide
intensity showing that unique fragments detected were
present only in negligible quantities (Figure 4B, upper
panel). The peptide fragments produced in both degrad-
ation conditions at each pH ranged from 4–19 amino acid
residues in length with several fragments harboring the
MHC class I epitope B57KF11. Fragments produced at pH
5.5 in crude lysate and endolysosomes were mostly longer
with 70% of the fragments between 13–19 amino acids in
length and fragments produced at pH 4.0 were shorter,
suggesting a stepwise degradation of longer fragments into
shorter peptides over the course of endolysosomal matur-
ation (Figure 4B, lower panel). Also, on average 40% of thepeptides produced in pH 5.5 in endolysosomes and crude
lysate and 30% of the peptides in pH 4.0 contained exten-
sions of the epitope B57KF11, showing that similar levels of
peptide degradation were present in both conditions
(Figure 4B, middle panel). We repeated the degradation
using lysate from a different PBMC donor and the peptide
5-ISW9-3 (MVHQAISPRTLNAWVKV), a 17 amino acid
long peptide from the HIV p24 protein encompassing epi-
tope B57ISW9 (Additional file 3: Figure S3). We compared
by mass spectrometry the identity and corresponding peak
sirface intensities of all peptides produced in purified
endolysosomes and in crude lysate at pH 4 and 5.5
(Additional file 3: Figure S3A). More than 95% of the peptide
intensities were contributed by fragments that were similar
between PBMC crude lysate and endolysosomes (Additional
file 3: Figure S3B, upper panel). Comparable levels of pep-
tides encompassed the epitope B57ISW9 and peptide length
distributions were observed between crude lysate and
endolysosomes (Additional file 3: Figure S3B, middle and
lower panels). However, in contrast to 5-KF11-3 the peptides
generated at pH 4.0 and pH 5.5 were similar for 5-ISW9-3,
suggesting that the peptides were generated by cathepsins
active at pH 4 and 5.5. The differences in the degradation
patterns of 5-KF11-3 and 5-ISW9-3 showed that peptide
fragments generated by cathepsin-mediated degradation is
dependent on the nature of the oligopeptide and its suscepti-
bility to cleavage by cathepsins present in different compart-
ments. We also determined the half-life of B57KF11
peptide in crude extracts at low pH versus endolysosomes
and found them to be similar (8 min in endolysosomes
and 6 min in crude lysate, both at pH 4.0) (data not
shown). These results in summary show that crude lysate
at pH 4.0 to pH 5.5 can be used to assess cathepsin-
mediated degradation of peptides and proteins in the place
of purified endolysosomes.
Discussion
Endolysosomes contain proteins that are involved in di-
verse functions in the cell [1]. Loss of activity in several
of these proteins leads to disease [2-5]. Current ap-
proaches to study endolysosomal proteins are not suffi-
cient to comprehensively understand the role of the
organelle in cellular functions and using purified organ-
elles is not feasible in studies involving access to limited
amount of material such as primary cells and tissues. Be-
cause several endolysosomal proteases are activated in
acidic pH [13], we have utilized this characteristic to de-
velop a simple approach to study the role of these prote-
ases in peptide degradation using crude PBMC lysate.
Most studies involving endolysosomal protease activity
use recombinant purified cathepsins [9], manipulations
such as gene knockouts in in vitro cell cultures [10]
or purified endolysosomes from cells or tissues [11].
In some cases, the results obtained are not the most
Figure 4 Degradation of peptides with crude lysate at pH 4.0 is equivalent to using purified endolysosomes. (A) A long HIV peptide,
5-KF11-3 (KVVEEKAFSPEVIPMFAAL) was subjected to degradation using PBMC or purified endolysosomes at pH 4.0 or pH 5.5. The fragments
produced were identified by mass spectrometry and the number of similar (light grey) and unique (dark grey) peptides between the two
conditions was determined. Peptides that were not detected are indicated in grey letters. The intensity of the peak of each peptide is indicated
for each experimental condition. (B) The sum of all peptide peak intensities was determined and the distribution of peak intensities in similar
(light grey) and unique (dark grey) fragments was calculated (upper). Of the total number of peptide fragments detected in each condition, the
percentage of fragments with (dark grey) and without (light grey) the B57KF11 epitope was calculated (middle panel). Similarly, the percentage of
fragments that measured 13–19 amino acids in length (dark grey), 8–12 amino acids (white) and lesser than 7 amino acids (black) was
determined. In all three cases, the average of the results from two MS runs of the same experiment was plotted.
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primary human tissues. Using the methodology de-
scribed here, it is possible to assess the activity of one or
simultaneously, many endolysosomal enzymes using
crude lysate prepared from primary cells. Also, by mo-
dulating the pH, specific enzymes can be activated and
cross-reactivity from other cytosolic proteins can be
avoided while allowing to follow protein degradation in
endolysosomal compartments. By using appropriate sub-
strates for each enzyme a novel diagnostic for lysosomal
protein disorders may be envisioned.
Another area of research that will benefit greatly from
this assay is antigen presentation. Antigen presentation
takes place in two different pathways inside the cell; theendogenous cytosolic pathway predominantly involved in
class I presentation and the exogenous endolysosomal
pathway involved in class II and class I epitope cross-
presentation [27]. One of the questions that has yet to be
addressed in antigen presentation is the characteristics
that govern efficient presentation of epitopes from a
pathogen-derived protein endocytosed in cells. To date,
the precise nature by which long pathogen-derived pro-
teins are degraded in endocytic compartments to produce
epitope length fragments is poorly defined. Despite the
critical role of protein degradation in endolysosomes to
elicit immune responses the nature of peptides cross-
presented by MHC-I and MHC-II is not well defined in
part due to the lack of adequate assays. Class II epitopes
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the limited knowledge of anchor residues within the MHC
class II protein and looser binding of peptides onto MHC-
II. Using our assay, it will be possible to study the degrad-
ation of pathogen-derived proteins or vaccine immunogens
in crude extracts at neutral vs. acidic pH and identify
epitopes produced in cytosol and endolysosomal compart-
ments by mass spectrometry. Using these peptide frag-
ments in in vivo antigen presentation assays and assaying
for CD4 or CD8 T cell stimulation will further help to de-
fine class I and class II epitopes that are produced after
intracellular processing and cross-presentation.
Vaccine immunogens (inactivated pathogens, purified
proteins, peptides, viral vectors) mostly enter dendritic
cells through endolysosomes for degradation followed by
presentation of peptides by MHC-I and MHC-II leading
to the priming of CD8 T cell responses and CD4 T helper
cell responses [27]. Knowledge of epitopes that are well
defined and preserved within cellular compartments will
enable efficient vaccine design. This is especially important
in light of chimeric vaccine immunogens (which includes
vaccines made of protein fragments separated by linkers,
peptides derived from conserved regions of proteins that
do not undergo mutations or peptides that include both
wild type and mutated versions separated by linkers), so as
to include peptides that will be efficiently processed and
presented on the cell surface [28]. With increased interest
in targeted vaccines, wherein, antigens can be engineered
to target specific compartments, once again, knowledge of
stable epitopes that are produced efficiently in each of the
targeted compartments is of immense importance. The
methodology described here will facilitate these studies and
bypass the need of intensive labor, access to large amounts
of primary human cells and complicated techniques.
Conclusions
In summary, we have shown that using crude PBMC cel-
lular extracts at low pH, endolysosomal protease activity
can be measured in a simple and efficient manner, results of
which can be used in several applications. We demonstrated
that by varying the pH in crude cellular extracts, we could
specifically activate certain cathepsins at each pH and
thereby monitor protease activity over the course of
endolysosomal maturation. We demonstrated the usefulness
of this assay in the context of antigen processing and showed
comparable results to using purified endolysosomes.
Methods
Human studies
Buffy coats from blood donated by anonymous healthy
donors were purchased from Massachusetts General
Hospital. Partners Human Research Committee (Boston,
MA) approved the use of buffy coats under protocol no.
2005P001218.Reagents and antibodies
Antibodies for Lysosome Associated Membrane Protein 1
(LAMP1) (sc-20011) and cathepsin S (sc-271619) were
purchased from Santa Cruz, beta actin (ab8227) and
calnexin (ab22595) from Abcam and proteasome α 7 sub-
unit (BML-PW8110-0100) from Enzo Lifesciences. All
chemicals were purchased from Sigma and fluorogenic
substrates were purchased from Enzo lifesciences. Highly
purified HIV peptides were purchased from Massachusetts
General Hospital peptide core facility or from Biosynthesis.
Endolysosome purification
Endolysosomes were purified from crude PBMC lysate
by differential centrifugation. PBMCs were isolated from
human buffy coats using Ficoll centrifugation [29]. Cells
resuspended in extraction buffer at a concentration of
5 × 108 cells/ml [30] were lysed using glass beads as in a
previous study done in our laboratory [31]. The cell
lysate was centrifuged at 1000g for 10 min at 4°C. The
supernatant was transferred to a new tube and cen-
trifuged at 20,000 g for 20 min at 4°C. The resulting pel-
let consists of endoplasmic reticulum, mitochondria and
endolysosomes. The supernatant corresponds to purified
cytosolic fraction. A step gradient ranging from 23% to
8% was built using an Optiprep based endolysosome iso-
lation kit (Sigma, LYSISO1). The tubes were centrifuged
at 100,000 g in a Beckmann Coulter tabletop centrifuge
at 4°C. 120 μl fractions were collected and further ana-
lyzed for endolysosomal enrichment.
Western blot
Following endolysosomal purification, 10μl of each frac-
tion and the post nuclear supernatant were loaded on a
4-12% SDS PAGE gradient gel (Invitrogen) run at a con-
stant 185V. The proteins were transferred to a PVDF
membrane (Fisher Scientific) using a semi-dry blotting
system (Bio-Rad) for 35 min at 20V. The membrane was
blocked using a blocking buffer [30] for 1 hour at RT
followed by incubation with the primary antibodies over-
night at 4C. The membrane was washed three times, 10
min each with 0.1% TBS Tween followed by incubation
with secondary antibodies, Goat anti rabbit (Licor,
926–68071) and Donkey anti mouse (Licor, 926–32212)
for 1 hour at RT. The membrane was washed again for
three times in wash buffer and imaged using a Licor
imaging system.
Enzyme activity assay
Activities of proteases were tested using a fluorogenic en-
zyme substrate specific for each endolysosomal cathepsin
[16]. For endolysosomal purification samples, 3 μl of each
fraction was added to 96 well plates. For analyzing cathe-
psin activity in different pH, 3 μg of crude PBMC lysate
was added to each well. Appropriate amount of the
Vaithilingam et al. BMC Cell Biology 2013, 14:35 Page 9 of 11
http://www.biomedcentral.com/1471-2121/14/35enzyme specific substrate (omni-cathepsin 50 μM, chymo-
tryptic activity of proteasome 100 μM and aminopeptidase
12.5 μM, cathepsin S 50 μM, cathepsin L 50 μM, cathepsin
D 10 μM, cathepsin K 50 μM, cathepsin B 50 μM) re-
suspended in 200 μl of buffer (20mM HEPES, 50mM po-
tassium acetate, 5 mM magnesium chloride, 1 mM ATP,
1mM DTT for proteasome, same buffer without ATP and
DTT for aminopeptidase and 50mM sodium chloride,
50mM potassium phosphate, 2 mM EDTA and 2mM
DTT for cathepsins) were added to each well containing
extracts or buffer (to control for background fluores-
cence). Fluorescence was measured every 5 minutes for 3
hours using a Victor-3 plate fluorescence reader (Perkin
Elmer, Boston, MA) as described before [29]. The resulting
fluorescence curves were plotted over time. For each con-
dition, the maximum rate of fluorescence emission was
calculated after background correction, which is equivalent
to the maximal rate of proteolytic hydrolysis. To verify the
specificity of each substrate hydrolysis, crude lysate was
pre-incubated with appropriate amounts of peptidase inhib-
itors: ZFL-COCHO 10 μM to inhibit Cathepsin S, pepstatin
100μM to inhibit Cathepsin D, BML-244 10 μM to inhibit
Cathepsin K, E64 50 μM to inhibit all cysteine cathepsins,
MG 132 10 μM to inhibit proteasome and bestatin 12.5 μM
to inhibit aminopeptidase for 30 minutes at room tem-
perature before addition of the fluorogenic substrate. Max-
imum slopes of the fluorescence over time curves in the
presence or absence of inhibitors showed a 35-100% spe-
cific inhibition of each activity (data not shown).
Acid phosphatase assay
The presence of acid phosphatase in endolysosomal frac-
tions was confirmed using a kit from Sigma (CS0740).
10 μl of each fraction was incubated with the substrate
in the provided substrate buffer for 10 min at 37°C. 200
μl of the stop solution (2M sodium hydroxide) was
added and the absorbance at 405 nM was measured. A
blank without any lysate serving as a negative control
and pure enzyme serving as a positive control was also
included in the experiment. The amount of acid phos-
phatase present was calculated using the formula, Units/
ml = (A405(sample)-A405(blank)) × 0.05 × 0.3 × DF/A405
(standard)x time x Venz, where DF is dilution factor and
Venz is volume of the pure enzyme.
Peptide degradation assay
The assay is adapted from previously published studies
from our laboratory [31]. 8 nM of peptide was incubated
with 30 μg of crude PBMC lysate in 250 μl of deg-
radation buffer (20 mM HEPES, 1 mM magnesium
chloride, 137 mM potassium acetate, 1 mM ATP) that
was adjusted to the appropriate pH. In studies involving
purified endolysosome, an acid phosphatase assay was
performed on the fractions and the amount of acidphosphatase activity was used to calculate the total
number of cells from which each fraction was derived.
Using this approach, equivalent amount of cytosol and
endolysosome that were derived from the same number
of cells were used in peptide degradation assays. For the
mass spectrometry analysis of peptide fragments, the
level of omni-cathepsin enzyme activity was assessed
using the activity assay and volume of crude lysate and
purified endolysosomes containing similar levels of the
enzyme activity was used in the degradation assay.
When using inhibitors, the compound was added to the
crude lysate before addition of the peptide and incubated
at room temperature for 30 minutes. The mixture was in-
cubated at 37°C and at each time point 50 μl were col-
lected and the reaction was stopped by adding 2.5 μl of
100% trifluoroacetic acid. Another 50 μl of the degradation
buffer was added to each sample and the amount of pep-
tide remaining was analyzed by RP-HPLC.Mass spectrometry analysis of peptide fragments
Following peptide degradation, the peptide fragments
produced were enriched using 10% trichloroacetic acid
precipitation and identified by in-house mass spectrometry
analysis as previously described [14]. After diluting the
product to 500 femtomole in 80% water, 15% acetonitrile,
5% trifluoroethanol, the peptides were resolved in RP-HPLC
on a C18 column (Nano-LC Eksigent) and electrosprayed
on an Orbitrap discovery mass spectrometer (Thermo). The
peptides were identified using Proteome Discoverer
software (Thermo) and the surface intensity of each peptide
peak corresponded to the amount of peptide present. The
peptide fragments were aligned using the Jalview software
and number of fragments present in both the conditions
were used to calculate the percentage of similar peptides
detected. The experiments were repeated twice using two
different endolysosomal preparations and degradation
products of each experiment were analyzed twice with the
mass spectrometer.Additional files
Additional file 1: Figure S1. Cysteine cathepsin activity is similar in live
cells and lysate. Human primary CD4 T cells were grown in R10-IL2. 5 ×
104 cells resuspended in PBS was added to each well. For lysate, the
volume of the lysate derived from 5 × 104 cells was calculated and added
to each well. When using inhibitors, E64 was added to the well and
preincubated for 30 min at 37C. Following incubation, the activity of an
omnicathepsin substrate was measured. Average and SD of 3 experiments.
Additional file 2: Figure S2. Cathepsin S and B substrates are cleaved
by both enzymes. Cathepsin B and S activity was measured in crude
PBMC lysate resuspended in pH 4.0 using fluoregenic subtrates. When
using inhibitors, lysate was preincubated with Cathepsin S, D, K, B and an
omnicathepsin inhibitor following which activity of the enzyme was
measured. The average maximum slope of the curve derived from three
replicates quantified in relative fluorescent units (RFU)/min is plotted.
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http://www.biomedcentral.com/1471-2121/14/35Additional file 3: Figure S3. Degradation of peptides with crude lysate
at pH 4.0 is equivalent to using purified endolysosomes for the
oligopeptide B57-5ISW9-3. A) A long HIV peptide, 5-ISW9-3
(MVHQAISPRTLNAWVKV) was subjected to degradation using PBMC or
purified endolysosomes at pH 4.0 or pH 5.5. The fragments produced
were identified by mass spectrometry and the number of similar (light
grey) and unique (dark grey) peptides between the two conditions was
determined. Peptides that were not detected are indicated in grey letters.
The surface of the peak of each peptide is indicated for each
experimental condition. (B) The sum of all peptide peak intensities was
determined and the distribution of peak intensities in similar (light grey)
and unique (dark grey) fragments was calculated (upper). Of the total
number of peptide fragments detected in each condition, the
percentage of fragments with (dark grey) and without (light grey) the
B57ISW9 epitope was calculated (middle panel). Similarly, the percentage
of fragments that measured 13–19 amino acids in length (dark grey),
8–12 amino acids (white) and lesser than 7 amino acids (black) was
determined. In all three cases, the average of the results from two MS
runs of the same experiment was plotted.
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